Overview
The goal of this clinical trial is to monitor hemodynamic differences between central veno-arterial extracorporeal membrane oxygenation (VA ECMO) and peripheral VA ECMO. The main question it aims to answer is:
- Efficacy of the different cannulation strategies for the establishment of for VA-ECMO circulation on hemodynamics and organ perfusion.
Participants require VA ECMO support, will be divided into two groups in an intention-to-treat analysis: central artery cannulation and peripheral artery cannulation.
Researchers will analyze different cannulation strategies for VA-ECMO and identify potential advantages and disadvantages for two groups of VA-ECMO.
Eligibility
Inclusion Criteria:
- Ageā„18 years
- Participants with cardiogenic shock
- Obtaining informed consent from participants or their affiliated beneficiaries
Exclusion Criteria:
- Irreversible heart failure
- Contraindications to anticoagulation therapy
- Uncontrolled bleeding
- Irreversible neurological pathology
- Participants limited to extracorporeal cardiopulmonary resuscitation